← FDA Drug Approvals (Drugs@FDA)
GABAPENTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENORES PHARMS · Approved 2025-08-07
Drug application
- FDA Application #
ANDA219319- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GABAPENTIN
- Generic name
- GABAPENTIN
- Active ingredients
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SENORES PHARMS
- Manufacturer
- STALLION LABORATORIES PRIVATE LIMITED
- First approval
- 2025-08-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown